Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1350377-66-0

Post Buying Request

1350377-66-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1350377-66-0 Usage

Classification

Boronic acid derivative

Common Uses

Reagent in organic chemistry synthesis
Development of pharmaceuticals
Development of agrochemicals
Materials science research

Chemical Structure

Contains a benzene ring
Boron atom attached to the benzene ring
Methoxy group attached to the benzene ring
Tetramethyl-1,3,2-dioxaborolan-2-yl group attached to the benzene ring

Importance

Essential building block in organic synthesis
Facilitates the creation of complex organic molecules

Safety Precautions

Requires careful handling
Adherence to proper safety protocols necessary
Potential hazards if mishandled

Check Digit Verification of cas no

The CAS Registry Mumber 1350377-66-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,0,3,7 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1350377-66:
(9*1)+(8*3)+(7*5)+(6*0)+(5*3)+(4*7)+(3*7)+(2*6)+(1*6)=150
150 % 10 = 0
So 1350377-66-0 is a valid CAS Registry Number.

1350377-66-0Relevant articles and documents

PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS

-

Paragraph 0142; 0143; 0144, (2021/03/05)

Provided herein are compounds of formula (I) as shown below, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.

PERK INHIBITING COMPOUNDS

-

Paragraph 0135-0137, (2021/03/05)

Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.

PERK INHIBITORS FOR TREATING VIRAL INFECTIONS

-

Page/Page column 66; 68, (2021/11/20)

Provided herein are methods for treating a viral infection in a patient, comprising administering to said patient a therapeutically effective amount of a PERK inhibitor selected from a compound having the structure (I):

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1350377-66-0